Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Dapagliflozin | hsa00030 | Pentose phosphate pathway | 6.81E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Dapagliflozin | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Dapagliflozin | hsa00510 | N-Glycan biosynthesis | 3.61E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Dapagliflozin | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Dapagliflozin | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Dapagliflozin | hsa00730 | Thiamine metabolism | 1.15E-03 | 2 | Q9Y6K8, P24666 | AK5, ACP1 | More | | Dapagliflozin | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Dapagliflozin | hsa00920 | Sulfur metabolism | 2.29E-02 | 1 | Q16762 | TST | More | | Dapagliflozin | hsa01100 | Metabolic pathways | 3.32E-02 | 34 | Q9NR34, P05089, O14521, P15144, O14732, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, O60701, Q9HCC0, P33121, P42330, P51854, Q08477, Q96EB6, P15907, Q9UNP4, Q9BX95, P37837, P32321, P60891, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q16718 | MAN1C1, ARG1, SDHD, ANPEP, IMPA2, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, UGDH, MCCC2, ACSL1, AKR1C3, TKTL1, CYP4F3, SIRT1, ST6GAL1, ST3GAL5, SGPP1, TALDO1, DCTD, PRPS1, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, NDUFA5 | More | | Dapagliflozin | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Dapagliflozin | hsa04064 | NF-kappa B signaling pathway | 4.25E-02 | 9 | P10415, O00463, P01375, Q04759, Q13077, Q16548, Q8WV28, P24522, P09341 | BCL2, TRAF5, TNF, PRKCQ, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1 | More | | Dapagliflozin | hsa04071 | Sphingolipid signaling pathway | 8.29E-03 | 7 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Dapagliflozin | hsa04122 | Sulfur relay system | 2.29E-02 | 1 | Q16762 | TST | More | | Dapagliflozin | hsa04340 | Hedgehog signaling pathway | 2.76E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Dapagliflozin | hsa04512 | ECM-receptor interaction | 2.00E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Dapagliflozin | hsa04514 | Cell adhesion molecules | 3.82E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Dapagliflozin | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Dapagliflozin | hsa04611 | Platelet activation | 2.25E-04 | 4 | P08514, Q15746, Q8WYR1, P07359 | ITGA2B, MYLK, PIK3R5, GP1BA | More | | Dapagliflozin | hsa04612 | Antigen processing and presentation | 1.64E-02 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Dapagliflozin | hsa04613 | Neutrophil extracellular trap formation | 9.55E-03 | 4 | P16109, Q99878, P08514, P07359 | SELP, H2AC14, ITGA2B, GP1BA | More | | Dapagliflozin | hsa04621 | NOD-like receptor signaling pathway | 4.27E-02 | 10 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, TNF, CXCL1, DEFA4 | More | | Dapagliflozin | hsa04657 | IL-17 signaling pathway | 2.81E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Dapagliflozin | hsa04658 | Th1 and Th2 cell differentiation | 7.47E-03 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Dapagliflozin | hsa04660 | T cell receptor signaling pathway | 2.52E-02 | 9 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, MAPK14, GSK3B | More | | Dapagliflozin | hsa04714 | Thermogenesis | 4.80E-02 | 6 | P22694, Q16539, Q969G3, P33121, Q16718, O14521 | PRKACB, MAPK14, SMARCE1, ACSL1, NDUFA5, SDHD | More | | Dapagliflozin | hsa04912 | GnRH signaling pathway | 4.72E-02 | 4 | Q16539, Q9Y6R4, Q14643, P22694 | MAPK14, MAP3K4, ITPR1, PRKACB | More | | Dapagliflozin | hsa04921 | Oxytocin signaling pathway | 4.91E-02 | 2 | Q15746, Q8WYR1 | MYLK, PIK3R5 | More | | Dapagliflozin | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Dapagliflozin | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Dapagliflozin | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Dapagliflozin | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Dapagliflozin | hsa05140 | Leishmaniasis | 4.80E-02 | 6 | O75015, P13765, O60603, P01375, Q16539, Q15080 | FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Dapagliflozin | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Dapagliflozin | hsa05144 | Malaria | 2.19E-03 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Dapagliflozin | hsa05145 | Toxoplasmosis | 3.96E-02 | 2 | P28068, Q16787 | HLA-DMB, LAMA3 | More | | Dapagliflozin | hsa05146 | Amoebiasis | 2.81E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Dapagliflozin | hsa05150 | Staphylococcus aureus infection | 4.13E-03 | 8 | P21730, P21462, O75015, P13765, Q16581, Q14532, P16109, P12838 | C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, KRT32, SELP, DEFA4 | More | | Dapagliflozin | hsa05165 | Human papillomavirus infection | 2.01E-02 | 3 | Q16787, Q02930, Q13315 | LAMA3, CREB5, ATM | More | | Dapagliflozin | hsa05166 | Human T-cell leukemia virus 1 infection | 2.91E-02 | 3 | Q02930, P28068, Q13315 | CREB5, HLA-DMB, ATM | More | | Dapagliflozin | hsa05217 | Basal cell carcinoma | 4.72E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Dapagliflozin | hsa05310 | Asthma | 2.34E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Dapagliflozin | hsa05321 | Inflammatory bowel disease | 2.22E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Dapagliflozin | hsa05332 | Graft-versus-host disease | 2.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Dapagliflozin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |